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ABSTRACT 
Mouse/3-glucuronidase  has a dual intracellular localization, being present in both 
endoplasmic reticulum  and lysosomes of several tissues.  Previous studies demon- 
strated  that the protein  egasyn is complexed with microsomal but  not lysosomal 
glucuronidase and that a mutant lacking egasyn is deficient in microsomal, but not 
lysosomal, glucuronidase.  By means of a  recently developed radioimmunoassay 
for egasyn, the relationship between microsomal glucuronidase levels and egasyn 
levels has been examined in various adult tissues, during postnatal development in 
liver,  and  after  androgen  induction  of  glucuronidase  in  kidney.  The  results 
indicate  that  the  relative  availability  of egasyn determines  the  balance  between 
glucuronidase  incorporation into membranes and that into lysosomes. 
Mouse glucuronidase is a useful system for studies 
of mechanisms bringing about the intracellular lo- 
calization of enzymes. A body of genetic and bio- 
chemical information concerning the expression of 
glucuronidase is available  (for reviews, see 3, 7, 
27), and the enzyme is unusual in that it has a dual 
intracellular location, being present  in  both lyso- 
somes and the membrane of the endoplasmic re- 
ticulum (microsomes) of several tissues (4, 5, 6, 9, 
19, 26). The intracellular distribution of glucuron- 
idase is tissue specific. All organs contain lysoso- 
mal glucuronidase but only some, including liver, 
kidney, and lung, contain  microsomal glucuroni- 
dase  (9,  10,  34).  The  enzyme  at  both  sites  is 
similar  in  thermal  stability,  antigenicity,  and  ki- 
netic parameters, and by means of genetic mutants 
it has been shown that the enzyme at both subcel- 
lular sites is derived from the same structural gene, 
Gus,  on chromosome 5 (8,  17, 18, 26, 28). 
Evidence both biochemical and genetic suggests 
that the binding of mouse glucuronidase to endo- 
plasmic reticulum  membrane  is stabilized  by the 
formation of noncovalent complexes with egasyn, 
a  membrane-bound  glycoprotein.  Glucuronidase 
is present in lysosomes as a free tetramer, termed 
L, of molecular weight 280,000 (19, 20, 34, 37). 
The microsomal enzyme is extracted by means of 
the detergent  Triton  X-100 as a  series of higher 
molecular  weight  aggregates,  termed  M1,  M2, 
M3,  and  M4 (34).  These consist of a glucuroni- 
dase  tetramer  core, termed  X,  complexed with, 
respectively, one, two, three or four molecules of 
egasyn, whose molecular weight is 64,000 (21,34, 
36). The two tetrameric forms of glucuronidase, X 
and L, appear to differ by covalent modification. 
At neutral  pH, form L  is slightly more negative 
than X, and there is a small difference in electro- 
phoretic mobility in the presence of sodium dode- 
cyl sulfate (SDS) (36). 
The assembly of the M form complexes depends 
upon a  genetic locus, Eg,  on chromosome 8  (9, 
10, 14, 34). A  defect at this locus, termed Eg  ~ is 
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absence  of glucuronidase  activity in  microsomes, 
although  Eg  o mice  contain  normal  levels  of the 
lysosomal enzyme (9, 10, 14, 34). Recently, it has 
been found that the primary defect in Eg  o  mice is a 
deficiency of egasyn (22). 
We now report evidence that in normal mice it 
is  the  quantitative  availability  of  egasyn  which 
determines  the  distribution  of glucuronidase  be- 
tween  lysosomes  and  microsomal  membranes. 
The  results  also  suggest  that  the  integration  of 
glucuronidase into microsomal membranes is con- 
trolled, among cell types and during development, 
by  the  production  of  egasyn.  These  studies  be- 
came  possible  with  the  availability  of  a  specific 
radioimmunoassay for egasyn (21). 
MATERIALS  AND  METHODS 
Animals and Homogenates 
The  inbred mouse  strains C57BL/6J  and  A/J  were 
obtained  from  The Jackson  Laboratory  (Bar Harbor, 
Me.)  and the inbred mouse strain YBR/WiCv  (YBR) 
was raised in our own colony. At the time of dissection, 
mice were about 2 mo of age. Tissues were homogenized 
in 9 vol of ice-cold 0.02 M  imidazole, 0.25 M sucrose, 
pH  7.4,  in  a  Polytron  (Brinkman  Instruments  Inc., 
Westbury,  N.Y.)  homogenizer,  and  were  stored  at 
-20~  For studies involving quantitation of the micro- 
somal  (M forms) of glucuronidase,  homogenates were 
used  fresh  or,  at  most,  once  frozen,  since  repeated 
freeze-thawing disrupts partially the M forms (34). 
Glucuronidase Assay 
A fluorimetric assay employing the substrate 4-meth- 
ylumbelliferyl-fl-D-glucuronide (Sigma Chemical Co., St. 
Louis, Mo.) was used. The sample was incubated at 37~ 
with 0.4 mM substrate and 0.1  M  sodium acetate, pH 
4.6, in a volume of 0.1 ml. The reaction was terminated 
by  the  addition of  1  ml  of 0.1  M  sodium  carbonate. 
Fluorescence was  determined with an Aminco 4-7439 
fluorimeter (American Instrument Co., Travenol Labs 
Inc., Silver Spring, Md.) equipped with a Coming 7-60 
excitation filter (Coming Glass Works, Science Products 
Div.,  Coming, N.Y.)  and a  Kodak  2A emission filter 
(Eastman  Kodak  Co.,  Rochester,  N.Y.).  One  unit of 
activity is that amount of enzyme hydrolyzing 1 /zmol of 
substrate per hour. 
Polyacrylamide  Gel Electrophoresis 
Electrophoresis was performed essentially as has been 
described previously (34). The detergent Triton X-100 
(Sigma) was added to homogenates to a final concentra- 
tion of 2%, and the mixture was allowed to stand on ice 
for 30 min, when it was centrifuged at 100,000 g for 30 
rain. This method results in the complete solubilization 
of microsomal glucuronidase and preserves the M forms 
intact (34).  Homogenate supernatant solutions (10/~1) 
were  applied  to  7%  polyacrylamide  gels  at  pH  8.1, 
prepared according to Clarke (1), and 300 v (constant 
voltage) were applied for 2.5 h. Glucuronidase activity 
was visualized with naphthol-AS-BI-glucuronide as sub- 
strate (11, 12). This method results in the clear separa- 
tion of the M  forms and the L  form of glucuronidase. 
Gels were scanned at 550 nm with a Coming densitome- 
ter (Coming Medical, Coming Glass Works, Medfield, 
Mass.).  Electrophoretic separation  of microsomal and 
lysosomal forms, followed by scanning and peak integra- 
tion, was used in estimating the fraction of glucuronidase 
present in microsomes The validity of this method has 
previously been demonstrated by showing that the  M 
forms of mouse organs, including androgen-induced kid- 
ney, are exclusively microsomal and that 90-95% of the 
L form is lysosomal (34, 36). 
Isolation of Egasyn and Preparation 
of Antibody 
These procedures were carried out as described previ- 
ously  (21).  Briefly,  microsomal  glucuronidase-egasyn 
complexes were released from the particulate fraction of 
mouse liver and kidney,  and were  precipitated by the 
addition of anti-mouse  fl-glucuronidase antibody, pre- 
pared  in  goats  (36,  37).  Egasyn  was  then  selectively 
released from these immunoprecipitates by either treat- 
ment with 0.5% sodium deoxycholate or incubation for 
5 rain at 50~  in 0.02 M Tris, 0.15 M NaC1, pH 7.5 (21). 
The  isolated  egasyn  was  homogeneous  as  judged  by 
polyacrylamide  gel  electrophoresis in  the  presence  of 
SDS by the method of Laemmli (15). The yield of egasyn 
from 100 g of pooled livers and kidneys averaged 100 t~g 
to 200/~g for most mouse strains. 
Antiserum to egasyn was prepared in rabbits by using 
intradermal injections at multiple sites of a total of about 
50 /zg of egasyn emulsified in Freund's complete adju- 
vant. Injections were given at intervals of about 2  wk, 
and  rabbits were  bled  at  8  wk.  Antiserum  to  egasyn 
reacted with free egasyn and with the M forms of glucu- 
ronidase but was unreactive towards glucuronidase that 
was not complexed with egasyn (21). Preimmune serum 
was unreactive with egasyn. 
Radioimmunoassay 
This  procedure  was  carried  out  as  previously  de- 
scribed  (21).  Briefly,  egasyn  was  labeled  with  ~5I 
(Amersham-Searle Corp.,  Arlington Heights,  Ill.,  car- 
der free) using chloramine-T essentially as described by 
Hunter (13). Samples to be assayed were first extracted 
with Triton X-100 at a final concentration of 2%. This 
procedure solubilized egasyn and egasyn-glucuronidase 
complexes (21). All dilutions for the assay were made in 
0.02 M Tris, 0.15 M NaCI, 0.1% Triton X-100, 0.1% 
bovine serum albumin, pH 7.4. Assays were carried out 
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Owens-Illinois,  Inc.,  Toledo,  Ohio).  The  sample  was 
mixed with antiegasyn  antibody in a volume of 100/zl in 
the presence of 1% sodium deoxycholate and incubated 
for 1 h at 37~  and 24 h at 4~  The antiegasyn  antibody 
added  represented about  a  500-fold  dilution of antise- 
rum and was enough to bind about 50% of the labeled 
egasyn, to be added at the next step. The presence of 
sodium deoxycholate was required to unmask antigenic 
sites of egasyn (21 ). Egasyn labeled with 1~I (4,000 cpm, 
in 50 /~1) was then added, and the mixture was further 
incubated for 1 h at 37~  and for 72 h at 4~  The free 
and antibody-bound  egasyns  were then separated by a 
double antibody precipitation method in which 30 p,1 of 
goat antibody  to rabbit  IgG and  40  /zl of 4%  control 
rabbit  serum  (as  carrier)  were  added.  This  mixture 
was incubated for 1 h at 37~  and for 4 h at 4~  when 
the immunoprecipitate was sedimented by centrifugation 
at 10,000  g for 10 min. The pellet was washed and the 
radioactivity  in the pellet was determined with a gamma 
counter (Biogamma model, Beckman Instruments, Inc., 
Fullerton, Calif.). A preparation of purified egasyn  was 
used  as the standard in each experiment. 
RESULTS 
Tissue  Distribution 
Previous studies have shown that the intracellular 
distribution of mouse glucuronidase differs among 
tissues (10,  34).  Although all organs contain lyso- 
somal glucuronidase activity, only some, including 
liver, kidney, and lung, contain microsomal glueu- 
ronidase.  Among  tissues,  the  levels  of  egasyn 
show a strong correlation with the levels of glueu- 
ronidase  in  microsomes  (Fig.  1  and  Table  I). 
Liver, the richest source of microsomal glucuroni- 
dase, contained about 56 ~g of egasyn per gram of 
tissue, and kidney, with less microsomal enzyme, 
contained  about  10  /zg  of  egasyn  per  gram  of 
tissue.  Brain  and  spleen  lacked  both  microsomal 
glucuronidase  and  egasyn,  while  lung  contained 
only  trace  levels  of  each  (Table  I).  Thus,  the 
production  of  egasyn  in  each  tissue  appears  to 
determine  the  proportion  of total  glucuronidase 
that  is  incorporated  into  microsomal  membrane. 
The lack of correlation between the total levels 
of glucuronidase  and  egasyn  among  tissues  sug- 
gests that the synthesis of each protein is regulated 
independently.  We have confirmed this by testing 
the response  in  kidney of both  proteins  after an- 
drogen  administration.  Androgens  induce  kidney 
glucuronidase  20-50  fold,  depending  upon  the 
mouse strain (35).  Egasyn, however, proved to be 
totally  nonresponsive  to  testosterone  (Table  II). 
In both liver and kidney, no significant differences 
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FIGURE 1  Radioimmunoassay  of  egasyn. Samples 
were prepared by homogenizing organs in 9 vol of 0.02 
M imidazole, 0.25 M sucrose,  pH 7.4, using a Polytron 
homogenizer  (Brinkman  Instruments).  Antibody  pre- 
pared  against  mouse  egasyn  was  incubated  first  with 
sample and then with egasyn labeled with iodine-125, as 
described in  Materials  and  Methods.  The presence of 
egasyn was detected by the displacement of radioactivity 
from the antiegasyn  antibody. Unlabeled, purified ega- 
syn was used as the standard. A  Distribution of egasyn 
in tissues of a typical C57BL/6J female. Egasyn standard 
(O-O),  liver (O-O),  kidney  (I-I),  lung ([2-r-1), 
spleen (A -  &) and brain (A -  A). B  Egasyn content of 
livers of strain  YBR mice (which carry the defective Eg  o 
allele)  and strain  C57BL/6J mice (which  carry the nor- 
mal Eg + allele).  Egasyn  standard  (O-I),  C57BL/6J 
(O- O), (C57BL/6J x  YBR)F1 (A -  A), YBR (A -  A). 
in  egasyn  content  were  observed  between  male 
and  female  animals  or  between  testosterone- 
treated  and  control  females.  Thus,  egasyn  and 
glucuronidase  are  under  independent  hormonal 
control. 
Development 
Preliminary  observations  of  Swank 1 suggested 
that  the  fraction  of glucuronidase  present  in  mi- 
i R. T. Swank. Personal communication. 
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Levels of Egasyn  and of Micros￿9  Glucuronidase  in Mouse Tissues 
Total glucuronidase  Microsomai  glucuronidase  Egasyn 
Strain  Tissue  mean --. S.E.  mean -+ S.E.  mean •  S.E. 
U/g tissue  uIg tissue  #gig tissue 
C57BL/6  liver  32.3  --- 1.9  12.0 -  0.5  56.1  --- 4.1 
C57BL/6  kidney  8.4 --- 0.1  1.9 -  0.1  9.1  -  0.6 
C57BL/6  lung  9.4 -  1.5  1.2  -  0.1  trace 
C57BL/6  spleen  25.5  --- 1.9  not detectable  not detectable 
C57BL/6  brain  2.2 -  0.1  not detectable  not detectable 
YBR  liver  21.1  --- 2.0  not detectable  not detectable 
YBR  kidney  5.9 -  0.3  not detectable  not detectable 
(C57BL/6  x  YBR)F1  liver  27.8 _-+ 1.4  10.0 _  0.6  25 _+ 1.8 
(C57BL/6  x  YBR)F1  kidney  6.7 -- 0.3  1.5  -- 0.1  - 
Female mice, about 60 days of age, were used. The fraction of glucuronidase in microsomes was determined by 
electrophoretic separation of lysosomal and micros￿9  forms, as described in Materials and Methods. 
TABLE II 
Effect of Androgen  upon the Levels of Egasyn  and 
Glucuronidase  in Kidney 
Egasyn  Glucuronidase 
strain  Control  Induced  Control  Induced 
#gig kidney  U/g kidney 
A/J  10.8  10.0  7.0  285 
C57BL/6J  9.1  8.0  5.2  92 
Female mice, about 60 days of age, were used. Testos- 
terone pellets (Schering Corp.) were implanted subcuta- 
neously, and mice were sacrificed about 2 wk after tes- 
tosterone implantation. Control mice received no testos- 
terone treatment. Assays were performed on the pooled 
kidneys of three or more mice. 
crosomal  membrane  undergoes  a  large  increase 
immediately  after birth.  As  a  further test  of the 
hypothesis  that  the  availability  of  egasyn  deter- 
mines the  extent  of membrane binding of glucu- 
ronidase  egasyn  concentrations and levels of mi- 
crosomal glucuronidase were compared in mouse 
liver during postnatal development.  Neither ega- 
syn nor micros￿9  glucuronidase is present to an 
appreciable extent in liver at birth (Fig. 2). After 
birth,  the  levels of both  egasyn  and  microsomal 
glucuronidase increase rapidly and then plateau at 
about  15  days of age  (Fig.  2).  Thus, the correla- 
tion between the levels of egasyn and microsomal 
glucuronidase  applies  not  only  to  the  different 
tissues but also during the development of a single 
tissue. 
Eg~  + Heterozygotes 
An  apparent  exception  to  the  correlation  be- 
tween levels of egasyn and membrane binding of 
glucuronidase is the observation that, although F~ 
heterozygotes of a cross between normal mice and 
the Eg  o mutant contain only half-normal levels of 
egasyn  (22),  they  nevertheless  retain  the  same 
proportion  of  microsomal  glucuronidase  as  their 
normal  parents  (Fig.  1  and Table  I).  This unex- 
pected result may be related to the presence of an 
excess  of  egasyn  in  liver  and  kidney.  We  have 
previously estimated that only about  10%  of the 
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FIGURE  2  Egasyn levels in developing mouse liver. All 
mice were of strain C57BL/6J and were born on day 0. 
Each point represents the pooled organs of 3 or more 
mice. Livers from mice on day 14 of gestation, about 6 
days  before  birth,  contained  no  detectable  egasyn. 
Egasyn (O-e),  microsomal glucuronidase (￿9  0). 
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Effect of Androgen on the Levels of Egasyn Complexed with Glueuronidase in Kidney 
Glucuronidase  forms 
Total  L  M1  M2  M3  M4 
Uninduced kidney 
glucuronidase ( U/g kidney)  5.2 
egasyn complexed with glu-  0.50 
curonidase  (p.g/g kidney) 
Induced kidney 
glucuronidase ( U/g kidney)  92.0 
egasyn complexed with glu-  8.1 
curonidase  ( lag/g kidney) 
3.8  0.17  0.24  0.47  0.47 
0  0.02  0.06  0.18  0.24 
53.4  20.7  11.3  5.5  1.1 
0  2.6  2.9  2.1  0.5 
Female C57BL/6J mice, about 60 days of age, were used. Mice were treated for 2 wk with testosterone as described 
in Table II. Kidneys were homogenized in 9 vol of 0.02 M imidazole, 0.25 M sucrose, pH 7.4, and the homogenates 
were extracted with 2% Triton X-100. The solutions were centrifuged at 100,000 x g for 60 min, and the supernatant 
solutions were electrophoresed and stained for glucuronidase  activity as described in Materials and Methods. The gels 
were scanned at 550 nm and peak integration gave the glucuronidase activity present in each form. One unit of 
glucuronidase activity corresponds to 0.6/~g of glucuronidase  2 (35). Using this value, and the molecular weights of 
egasyn (64,000)  and  glucuronidase (75,000  per  subunit),  and  assuming that  M1,  M2,  M3  and  M4  contain, 
respectively,  1,  2,  3,  and  4  molecules of egasyn per  glucuronidase tetramer,  the  amount  of egasyn in  each 
glucuronidase form was calculated. 
egasyn in C57BL/6J liver is complexed with glucu- 
ronidase (21), and from the distribution of glucu- 
ronidase among its microsomal forms we estimate 
that only a small fraction of egasyn in uninduced 
female  kidney is  complexed  with  glucuronidase 
(Table III). 
To test whether this explanation is correct, we 
have taken advantage of the androgen inducibility 
of glucuronidase, but  not egasyn  (Table II),  to 
compare heterozygotes and their normal counter- 
parts under conditions in which egasyn is not in 
excess.  Swank  and  Paigen  (34)  have  previously 
shown that there is a large increase in microsomal 
as well as lysosomal glucuronidase in kidney after 
androgen induction. Following induction of nor- 
mal kidney, virtually all of the  egasyn becomes 
complexed with glucuronidase (Table III). This is 
also reflected in a shift in the proportion of the M 
forms of glucuronidase toward the lower molecu- 
lar  weight  forms  containing fewer  molecules of 
egasyn  (Table  III).  In  strains  which  have  even 
higher  inducibility  of  glucuronidase  than  the 
C57BL/6 strain used in these experiments, small 
amounts of  uncomplexed X  glucuronidase have 
been  detected  in  normal  induced  kidney  (34). 
These observations suggest that in normal induced 
kidney the supply of egasyn available for complex- 
ing with glucuronidase becomes depleted.  When 
Eg~  § heterozygotes, which contain about half 
2 A. J. Lusis and K. Paigen, 1976. Unpublished results. 
as  much  egasyn as  normal mice  (22),  were  in- 
duced  for  glucuronidase, they  contained signifi- 
cantly less of the microsomal forms of glucuroni- 
dase  than  did  induced Eg+/Eg + mice  (Fig.  3). 
Also,  the  relative  amounts  of  the  microsomal 
forms of glucuronidase differed between the two 
types  of  mice;  while  normal homozygotes  con- 
tained  significant amounts of  M2  and  M3,  the 
heterozygotes contained primarily M1 and the un- 
complexed  glucuronidase  tetramer  X  (Fig.  3). 
Thus,  Eg~  + heterozygotes  that  contain half- 
normal levels of egasyn also have reduced levels of 
microsomal glucuronidase when conditions are ar- 
ranged so that egasyn is no longer in excess. 
DISCUSSION 
Our experimental observations indicate that  the 
availability of egasyn is a primary factor in deter- 
mining the partition of glucuronidase between ly- 
sosomes  and  endoplasmic  reticulum.  Levels  of 
egasyn and microsomal glucuronidase are strongly 
correlated in different tissues and during the de- 
velopment of a single tissue. Also, previous obser- 
vations show that phenobarbital is able to induce 
egasyn  about  two-fold,  and  that  accompanying 
this induction is a significant shift in the subcellular 
distribution of glucuronidase from  lysosomes to 
microsomes, although the total level of glucuroni- 
dase remains constant (25). 
There is one anomaly in the quantitative rela- 
tionship between egasyn levels and the membrane 
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FIGURE 3  Polyacrylamide gel electrophoresis of glucu- 
ronidase from  kidneys of androgen-induced  mice.  Fe- 
male  mice,  about 60  days of age, were  pelleted with 
testosterone as described in Table II and were sacrificed 
about  10 days after pelleting.  Kidneys were  homoge- 
nized in 0.02 M imidazole, 0.25 M sucrose, pH 7.4, and 
these were extracted with 2% Triton X-100 and centri- 
fuged at 100,000 g for 30 rain. Supernatant solutions (10 
/~l) were applied to polyacrylamide gels, and electropho- 
resis was performed as described in Materials and Meth- 
ods. Gels were  stained for glucuronidase  activity and 
scanned at 550 nm. The separation of the X and L forms 
of glucuronidase  was  incomplete,  and X  is seen  as a 
shoulder  behind  L. 
binding  of  glucuronidase.  Halving  the  egasyn 
level, by making animals genetically heterozygous 
(Eg~  does not cause a significant shift in the 
subcellular localization of glucuronidase unless the 
animals are pushed to synthesize unusually large 
amounts of glucuronidase. However, doubling the 
egasyn level, via phenobarbital induction, is able 
to cause a significant shift in the subcellular locali- 
zation  of glucuronidase  even  when  there  is  no 
change  in  enzyme activity (25).  The explanation 
for  this  may  be  related  to  the  fact  that  genetic 
manipulation to reduce egasyn levels has no effect 
on  the  synthesis  of  other  membrane  proteins, 
whereas phenobarbital causes a generalized prolif- 
eration of endoplasmic reticulum  protein as well 
as an  induction of egasyn.  The  additional mem- 
brane components induced by phenobarbital may 
influence  the  interaction  between  glucuronidase 
and egasyn. 
The syntheses of egasyn and glucuronidase ap- 
pear to be regulated independently. There is no 
correlation between the total levels of egasyn and 
glucuronidase  among  tissues,  and  glucuronidase 
but not egasyn is induced by androgen in kidney. 
This suggests that the major factor controlling the 
integration  of  glucuronidase  into  membranes, 
among cell types and during development, is the 
regulation of egasyn synthesis. In relation to this, a 
particularly interesting question that remains to be 
answered  is  whether  egasyn  is  complexed  with 
proteins other than  glucuronidase.  In both  liver 
and  kidney,  only  a  small  fraction  of  the  total 
egasyn is complexed with glucuronidase. That the 
remainder may well be associated with other pro- 
teins is suggested by the observation that antigenic 
sites  of egasyn  are  unmasked  under  conditions 
that  would  dissociate  egasyn-protein  complexes 
(21).  Thus,  egasyn  synthesis  may  regulate  the 
membrane  binding of a  family of proteins,  only 
one of which is glucuronidase. 
Some evidence suggests that egasyn functions to 
stabilize the membrane binding of glucuronidase, 
once  it has  occurred,  rather  than  to  initiate the 
binding. First, under conditions of egasyn deple- 
tion, such as in androgen-induced kidneys of some 
mouse strains, small amounts of X glucuronidase, 
not complexed with egasyn, are present in mem- 
branes  (34).  Second,  Ganschow  and  Smith  3,  by 
following  the  incorporation  of  radioactively la- 
beled amino acids into microsomal and lysosomal 
glucuronidase,  have  obtained  evidence  that  Eg  o 
mice synthesize approximately normal amounts of 
membrane-bound X glucuronidase but that in the 
absence of egasyn the membrane-bound glucuron- 
idase is rapidly removed. 
The  intracellular forms  of glucuronidase  have 
been examined in rabbit and rat tissues as well as 
in  mice  (2).  Livers of both  rabbit and  rat  have 
large amounts of glucuronidase activity in micro- 
somes as well as lysosomes, and the microsomal 
forms are extracted by Triton X-100 (3, 24). Bio- 
chemical studies suggest that, as in mice, the en- 
zyme  at  both  subcellular sites is derived from  a 
common  structural  gene,  although  genetic  evi- 
dence of this has not been obtained (2,  24).  Mi- 
crosomal glucuronidase and lysosomal glucuroni- 
dase in rat liver differ in charge, but no evidence 
of macromolecular complexes has been presented 
3 R. Ganschow and K. Smith. Personal communication. 
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a  series of glucuronidase  molecular weight forms 
similar  to  those  observed  in  mice;  however,  at- 
tempts to correlate these with different subcellular 
fractions  have  not  yielded  results  which  are  as 
clear as those obtained with mouse tissues (3). 
There  is now considerable  evidence in support 
of the original concept that the microsomal forms 
of glucuronidase  exist  complexed  with  egasyn  in 
endoplasmic reticulum,  and that  these complexes 
are required for maintenance  of glucuronidase  in 
membranes.  It  is  likely  that  this  mechanism  of 
membrane  binding,  involving noncovalent  com- 
plexing with a specific integral membrane protein, 
is  used  widely among biological systems.  Studies 
involving  several  "peripheral"  membrane  pro- 
teins,  including  mitochondrial  ATPase  (15,  23, 
29),  cytochrome  c  (30,  31),  and  spectrin  (33), 
have  been  reviewed by  Singer  (30).  In  common 
with glucuronidase, each of these proteins appears 
to be anchored to membrane by specific noncova- 
lent interaction with integral membrane proteins. 
Membrane  binding by this  mechanism  may have 
special biological utility. Structurally, it provides a 
means of stabilizing the attachment of highly polar 
molecules,  such  as  glucuronidase  (37),  to  mem- 
branes,  and it allows considerable exposure of the 
bound protein to the cytosol, which may be impor- 
tant  for  the  functioning  of  certain  enzymes.  In 
terms of regulation, it allows independent control 
of the total activity and intracellular distribution of 
an enzyme, and provides a mechanism for coordi- 
nating the membrane binding of a set of enzymes. 
The studies with egasyn now provide evidence that 
integral anchor proteins such as egasyn may have a 
~egulatory as well as a  structural  function. 
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